US 10590121
Kinase inhibitors and methods for making and using
granted A61PA61P29/00
Quick answer
US patent 10590121 (Kinase inhibitors and methods for making and using) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P29/00